Immunomodulatory mechanisms of mesenchymal stem cells and their potential clinical applications
Y Huang, Q Wu, PKH Tam - International Journal of Molecular Sciences, 2022 - mdpi.com
Mesenchymal stem cells (MSCs) are multipotent stem cells with the capacity of self-renewal,
homing, and low immunogenicity. These distinct biological characteristics have already …
homing, and low immunogenicity. These distinct biological characteristics have already …
Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and …
PS Couto, N Al-Arawe, IS Filgueiras… - Frontiers in …, 2023 - frontiersin.org
During the pandemic of severe respiratory distress syndrome coronavirus 2 (SARS-CoV2),
many novel therapeutic modalities to treat Coronavirus 2019 induced disease (COVID-19) …
many novel therapeutic modalities to treat Coronavirus 2019 induced disease (COVID-19) …
Effectiveness and safety of normoxic allogenic umbilical cord mesenchymal stem cells administered as adjunctive treatment in patients with severe COVID-19
Inflammatory response in COVID-19 contributes greatly to disease severity. Mesenchymal
Stem Cells (MSCs) have the potential to alleviate inflammation and reduce mortality and …
Stem Cells (MSCs) have the potential to alleviate inflammation and reduce mortality and …
Pathogenic role of adipose tissue-derived mesenchymal stem cells in obesity and obesity-related inflammatory diseases
J Pestel, F Blangero, A Eljaafari - Cells, 2023 - mdpi.com
Adipose tissue-derived mesenchymal stem cells (ASCs) are adult stem cells, endowed with
self-renewal, multipotent capacities, and immunomodulatory properties, as mesenchymal …
self-renewal, multipotent capacities, and immunomodulatory properties, as mesenchymal …
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial
TT Li, B Zhang, H Fang, M Shi, WQ Yao, Y Li… - …, 2023 - thelancet.com
Background Long-term effects of human mesenchymal stem cell (MSC) treatment on COVID-
19 patients have not been fully characterized. The aim of this study was to evaluate the …
19 patients have not been fully characterized. The aim of this study was to evaluate the …
Mesenchymal stem cell therapy for COVID-19 infection
SMM Alavi-Dana, Y Gholami, M Meghdadi… - …, 2024 - Springer
COVID-19 emerged in December 2019 in Wuhan, China, spread worldwide rapidly, and
caused millions of deaths in a short time. Many preclinical and clinical studies were …
caused millions of deaths in a short time. Many preclinical and clinical studies were …
[HTML][HTML] Clinical progress in MSC-based therapies for the management of severe COVID-19
M Rossello-Gelabert, A Gonzalez-Pujana… - Cytokine & Growth …, 2022 - Elsevier
Considering the high impact that severe Coronavirus disease 2019 (COVID-19) cases still
pose on public health and their complex pharmacological management, the search for new …
pose on public health and their complex pharmacological management, the search for new …
Effect and safety of mesenchymal stem cells for patients with COVID‐19: Systematic review and meta‐analysis with trial sequential analysis
The objective of this study was to assess whether mesenchymal stem cells (MSCs) therapy
could offer survival advantages for patients with novel coronavirus disease 2019 (COVID …
could offer survival advantages for patients with novel coronavirus disease 2019 (COVID …
Efficient delivery of mesenchymal stem/stromal cells to injured liver by surface PEGylation
Y Takayama, K Kusamori, Y Katsurada… - Stem Cell Research & …, 2023 - Springer
Background Mesenchymal stem/stromal cells (MSCs) have been used in clinical trials for
various diseases. These have certain notable functions such as homing to inflammation …
various diseases. These have certain notable functions such as homing to inflammation …
Effectiveness of RCTs Pooling Evidence on Mesenchymal Stem Cell (MSC) Therapeutic Applications During COVID-19 Epidemic: A Systematic Review
UR Kandula, AD Wake - Biologics: Targets and Therapy, 2023 - Taylor & Francis
Background Global pandemic identified as coronavirus disease 2019 (COVID-19) has
resulted in a variety of clinical symptoms, from asymptomatic carriers to those with severe …
resulted in a variety of clinical symptoms, from asymptomatic carriers to those with severe …